# FDA Inspection 1192283 - Octapharma Plasma Inc - December 01, 2022

Source: https://www.globalkeysolutions.net/records/fda_inspections/octapharma-plasma-inc/04393938-3343-495b-83d9-736c569622b9
Source feed: FDA_Inspections

> FDA Inspection 1192283 for Octapharma Plasma Inc on December 01, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1192283
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2022-12-01
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1192283 - 2022-12-01](https://www.globalkeysolutions.net/records/fda_inspections/octapharma-plasma-inc/52c369d4-ed24-4b6b-a50d-2b4803994b37)
- [FDA Inspection 1036907 - 2017-11-28](https://www.globalkeysolutions.net/records/fda_inspections/octapharma-plasma-inc/7cfd9892-0c2e-4f91-ba5b-505944e4ff0b)
- [FDA Inspection 959258 - 2016-02-11](https://www.globalkeysolutions.net/records/fda_inspections/octapharma-plasma-inc/df36706e-fa26-4759-8ffa-424e5374c2f1)
- [FDA Inspection 887853 - 2014-07-18](https://www.globalkeysolutions.net/records/fda_inspections/octapharma-plasma-inc/251b1907-d5f7-44af-81ba-86362a55dd02)
- [FDA Inspection 777497 - 2012-04-18](https://www.globalkeysolutions.net/records/fda_inspections/octapharma-plasma-inc/4f533af3-0e99-48a1-8df7-ba3188804d1e)

Company: https://www.globalkeysolutions.net/companies/octapharma-plasma-inc/49b37132-2bd9-4529-9143-ef4234daf2ca

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d